UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bath salts and synthetic cathinones: An emerging designer drug phenomenon

Life sciences (1973), 2014-02, Vol.97 (1), p.2-8

2014

Volltextzugriff (PDF)

Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease

Pharmacological reviews, 2015-10, Vol.67 (4), p.1005-1024

2015

Volltextzugriff (PDF)

Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: A population-based assessment

Drug and alcohol dependence, 2015-01, Vol.146, p.30-38

2015

Volltextzugriff (PDF)

4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse

The Journal of pharmacology and experimental therapeutics, 2011-11, Vol.339 (2), p.530-536

2011

Volltextzugriff (PDF)

Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization

Journal of neurochemistry, 2012-10, Vol.123 (2), p.288-297

2012

Volltextzugriff (PDF)

Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: Neurotoxic and therapeutic implications

Neuropharmacology, 2009-01, Vol.56 (Suppl 1), p.133-138

2009

Volltextzugriff (PDF)

Mechanisms of methamphetamine-induced dopaminergic neurotoxicity

The AAPS journal, 2006-06, Vol.8 (2), p.E413-E418

2006

Volltextzugriff (PDF)

The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine‐induced dopaminergic deficits

Journal of neurochemistry, 2007-05, Vol.101 (4), p.883-888

2007

Volltextzugriff (PDF)

Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure

The Journal of pharmacology and experimental therapeutics, 2012-02, Vol.340 (2), p.295-303

2012

Volltextzugriff (PDF)

Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits

The international journal of neuropsychopharmacology, 2015-07, Vol.18 (12), p.pyv073

2015

Volltextzugriff (PDF)

Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits

The Journal of pharmacology and experimental therapeutics, 2015-12, Vol.355 (3), p.463-472

2015

Volltextzugriff (PDF)

Role of monoamine transporters in mediating psychostimulant effects

The AAPS journal, 2005-12, Vol.7 (4), p.E847-E851

2005

Volltextzugriff (PDF)

Impact of psychostimulants on vesicular monoamine transporter function

European journal of pharmacology, 2003-10, Vol.479 (1), p.283-289

2003

Volltextzugriff (PDF)

Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit/hyperactivity disorder

Neuropsychopharmacology (New York, N.Y.), 2018-12, Vol.43 (13), p.2548-2555

2018

Volltextzugriff (PDF)

Differential effects of stimulants on monoaminergic transporters: Pharmacological consequences and implications for neurotoxicity

European Journal of Pharmacology, 2000-10, Vol.406 (1), p.1-13

2000

Volltextzugriff (PDF)

New insights into the mechanism of action of amphetamines

Annual review of pharmacology and toxicology, 2007-01, Vol.47 (1), p.681-698

2007

Volltextzugriff (PDF)

Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits

The Journal of pharmacology and experimental therapeutics, 2003-03, Vol.304 (3), p.1181-1187

2003

Volltextzugriff (PDF)

Mechanisms underlying methamphetamine-induced dopamine transporter complex formation

The Journal of pharmacology and experimental therapeutics, 2009-04, Vol.329 (1), p.169-174

2009

Volltextzugriff (PDF)

Methamphetamine Rapidly Decreases Vesicular Dopamine Uptake

Journal of neurochemistry, 2000-05, Vol.74 (5), p.2221-2223

2000

Volltextzugriff (PDF)

Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles

The Journal of pharmacology and experimental therapeutics, 2007-11, Vol.323 (2), p.738-745

2007

Volltextzugriff (PDF)

Methamphetamine Increases Dopamine Transporter Higher Molecular Weight Complex Formation via a Dopamine- and Hyperthermia-Associated Mechanism

The Journal of neuroscience, 2004-03, Vol.24 (13), p.3436-3443

2004

Volltextzugriff (PDF)

Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activation

The Journal of pharmacology and experimental therapeutics, 2009-03, Vol.328 (3), p.807-812

2009

Volltextzugriff (PDF)

Methcathinone decreases dopamine transporter function: Role of protein kinase C

Journal of neurochemistry, 2021-10, Vol.159 (1), p.116-127

2021

Volltextzugriff (PDF)

Methylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and dopamine D2 receptors

The Journal of pharmacology and experimental therapeutics, 2008-10, Vol.327 (1), p.161-167

2008

Volltextzugriff (PDF)

Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity

The Journal of pharmacology and experimental therapeutics, 2005-09, Vol.314 (3), p.1087-1092

2005

Volltextzugriff (PDF)

1 – 25 von 261

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(250)
Mit Volltextzugriff
(220)

Publikationsform

Sprache

Englisch
(261)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bath salts and synthetic cathinones: An emerging designer drug phenomenon

Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease

Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: A population-based assessment

4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse

Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization

Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: Neurotoxic and therapeutic implications

Mechanisms of methamphetamine-induced dopaminergic neurotoxicity

The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine‐induced dopaminergic deficits

Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure

Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits

Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits

Role of monoamine transporters in mediating psychostimulant effects

Impact of psychostimulants on vesicular monoamine transporter function

Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit/hyperactivity disorder

Differential effects of stimulants on monoaminergic transporters: Pharmacological consequences and implications for neurotoxicity

New insights into the mechanism of action of amphetamines

Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits

Mechanisms underlying methamphetamine-induced dopamine transporter complex formation

Methamphetamine Rapidly Decreases Vesicular Dopamine Uptake

Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles

Methamphetamine Increases Dopamine Transporter Higher Molecular Weight Complex Formation via a Dopamine- and Hyperthermia-Associated Mechanism

Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activation

Methcathinone decreases dopamine transporter function: Role of protein kinase C

Methylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and dopamine D2 receptors

Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity

Suchergebnisse filtern